COLLPLANT BIOTECHNOLOGIESNEW ($CLGN) is expected to release its quarterly earnings data on Wednesday, November 26th before market open, per Finnhub. Analysts are expecting revenue of $4,941,390 and earnings of $0.16 per share.
You can see Quiver Quantitative's $CLGN stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
COLLPLANT BIOTECHNOLOGIESNEW Hedge Fund Activity
We have seen 8 institutional investors add shares of COLLPLANT BIOTECHNOLOGIESNEW stock to their portfolio, and 8 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HEIGHTS CAPITAL MANAGEMENT, INC removed 255,824 shares (-93.0%) from their portfolio in Q3 2025, for an estimated $688,166
- ANSON FUNDS MANAGEMENT LP removed 159,401 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $428,788
- VILLERE ST DENIS J & CO LLC added 41,850 shares (+7.7%) to their portfolio in Q3 2025, for an estimated $112,576
- AMH EQUITY LTD added 39,151 shares (+24.3%) to their portfolio in Q3 2025, for an estimated $105,316
- UBS GROUP AG removed 24,074 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $32,740
- RENAISSANCE TECHNOLOGIES LLC removed 19,700 shares (-47.4%) from their portfolio in Q3 2025, for an estimated $52,993
- PATHSTONE HOLDINGS, LLC removed 17,000 shares (-50.0%) from their portfolio in Q3 2025, for an estimated $45,730
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
COLLPLANT BIOTECHNOLOGIESNEW Analyst Ratings
Wall Street analysts have issued reports on $CLGN in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- D. Boral Capital issued a "Buy" rating on 10/20/2025
- HC Wainwright & Co. issued a "Buy" rating on 08/21/2025
To track analyst ratings and price targets for COLLPLANT BIOTECHNOLOGIESNEW, check out Quiver Quantitative's $CLGN forecast page.
COLLPLANT BIOTECHNOLOGIESNEW Price Targets
Multiple analysts have issued price targets for $CLGN recently. We have seen 2 analysts offer price targets for $CLGN in the last 6 months, with a median target of $11.5.
Here are some recent targets:
- Jason Kolbert from D. Boral Capital set a target price of $12.0 on 10/20/2025
- Swayampakula Ramakanth from HC Wainwright & Co. set a target price of $11.0 on 08/21/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
